Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Briens

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 21, 2019
[Adaptive radiotherapy: Strategies and benefits depending on tumor localization]A Briens, J Castelli, A Barateau, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 30, 2020
PET and MRI guided adaptive radiotherapy: Rational, feasibility and benefitS Thureau, A Briens, P Decazes, et al.
Cell Death & Disease|October 16, 2015
Conformations of tissue plasminogen activator (tPA) orchestrate neuronal survival by a crosstalk between EGFR and NMDART Bertrand, F Lesept, A Chevilley, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 14, 2024
[Does radiation therapy for prostate cancer increase the risk of second cancers?]A Boué-Raflé, A Briens, S Supiot, et al.
Cell Death and Differentiation|June 30, 2012
Unveiling an exceptional zymogen: the single-chain form of tPA is a selective activator of NMDA receptor-dependent signaling and neurotoxicityJ Parcq, T Bertrand, A Montagne, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 21, 2019
[Adaptive radiotherapy: Strategies and benefits depending on tumor localization]A Briens, J Castelli, A Barateau, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 30, 2020
PET and MRI guided adaptive radiotherapy: Rational, feasibility and benefitS Thureau, A Briens, P Decazes, et al.
Cell Death & Disease|October 16, 2015
Conformations of tissue plasminogen activator (tPA) orchestrate neuronal survival by a crosstalk between EGFR and NMDART Bertrand, F Lesept, A Chevilley, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 14, 2024
[Does radiation therapy for prostate cancer increase the risk of second cancers?]A Boué-Raflé, A Briens, S Supiot, et al.
Cell Death and Differentiation|June 30, 2012
Unveiling an exceptional zymogen: the single-chain form of tPA is a selective activator of NMDA receptor-dependent signaling and neurotoxicityJ Parcq, T Bertrand, A Montagne, et al.
Pageof 1